Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Salient Pharmaceuticals logo — Pioneering the natural way to combat toxins and inflammation...

Salient Pharmaceuticals

Pioneering the natural way to combat toxins and inflammation through an innovative, all-natural mineral composition.

Founded 2007 Non Equity Assistance Total: $2.00M Biopharma, Biotechnology +2

General Information

Company Name Salient Pharmaceuticals
Founded Year 2007
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Non Equity Assistance
Social

BounceWatch is an independent company data service, not affiliated with Salient Pharmaceuticals. To contact Salient Pharmaceuticals, visit salientpharmaceuticals.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Salient Pharmaceuticals compare?

A PDF of Salient Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Salient Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Salient Pharmaceuticals

Salient Pharmaceuticals is a Texas-based startup established in 2007, focusing on the pharmaceutical potential of a unique, naturally occurring mineral composition. The company's flagship compound, CASAD™, aims to combat toxins and inflammation, with applications ranging from Cancer Therapy-Induced Diarrhea to infectious diseases and chronic gastrointestinal issues. Additionally, it holds promise as a rescue agent for medications with toxic side effects. The last investment in the company was a Non Equity Assistance investment from Texas Venture Labs on 18 August 2011. Salient Pharmaceuticals operates in the Biopharma, Biotechnology, Health Care, and Pharmaceutical industries, pioneering an all-natural approach to addressing health challenges.

Business keywords: biopharmaceuticals, natural minerals, toxin absorption, inflammation, diarrhea treatment, pharmaceutical innovation, drug development, Texas startups, gastrointestinal disorders, toxicity rescue agents

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance Undisclosed 1
Texas Venture Labs
18 Aug 2011
Venture Round $2.00M 1
Texas Wide Open for Business
29 Jan 2010

Salient Pharmaceuticals Alternatives & Competitors

View All Alternatives
Salient Pharmaceuticals vs
Nicox
Nicox France

Maintain vision and improve ocular health

Post-IPO Equity
46 employees
Biotechnology, Health Care
Salient Pharmaceuticals vs
Acticor Biotech
Acticor Biotech France

To treat the acute phase of ischemic stroke !

Post-IPO Equity
18 employees
Biopharma, Biotechnology
Salient Pharmaceuticals vs
Chiasma
Chiasma

Leveraging innovative technology to convert injectable drugs into oral treatments for enhanced absor...

Post-IPO Equity
Biopharma, Biotechnology
View all alternatives

FAQ About Salient Pharmaceuticals

Pioneering the natural way to combat toxins and inflammation through an innovative, all-natural mineral composition.
Salient Pharmaceuticals was founded in 2007.
Salient Pharmaceuticals operates in Biopharma, Biotechnology, Health Care and Pharmaceutical. Its work centres on biopharmaceuticals, natural minerals, toxin absorption and inflammation.
Salient Pharmaceuticals has completed 2 funding rounds, raising a total of $2.00M. The latest funding stage is Non Equity Assistance.
Top alternatives and competitors to Salient Pharmaceuticals include Nicox, Acticor Biotech, Chiasma, Movetis NV, Myrobalan Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Salient Pharmaceuticals and Nicox are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Salient Pharmaceuticals, https://bouncewatch.com/company/salient-pharmaceuticals, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes